Skip to content
  • YouTube
  • Facebook
  • LinkedIn
Pharm'Up

Pharm'Up

An E-platform for Learners

https://www.youtube.com/watch?v=xuTKPPZrxy4
Primary Menu
  • Home
  • News
  • Industries
  • Disease
  • Drugs
  • Events
  • Jobs
  • Trainings
  • Conferences
  • Syllabus
  • Previous Papers
  • Notes
  • Colleges
Live
  • Home
  • 2025
  • August
  • 23
  • Gait Retraining: A Drug-Free, Surgery-Free Path to Relieving Arthritic Knee Pain
  • Pharma News

Gait Retraining: A Drug-Free, Surgery-Free Path to Relieving Arthritic Knee Pain

Pharm'Up 3 min read

A groundbreaking study from researchers at the University of Utah, New York University, and Stanford University has demonstrated that gait retraining, a simple and non-invasive intervention, can effectively relieve pain and slow the progression of knee osteoarthritis. This research, published in The Lancet Rheumatology, offers a potential new treatment option for the millions of people who suffer from this debilitating condition, providing an alternative to medication and, eventually, joint replacement surgery.

A Personalized Approach to an Old Idea

Osteoarthritis, a condition where the cartilage in joints breaks down, affects nearly a quarter of adults over 40. While the idea of a biomechanical intervention is not new—research has long known that changing how a person walks can reduce the load on their knee—this is the first placebo-controlled study to prove its effectiveness.

The study’s success hinged on a personalized approach. Using pressure-sensitive treadmills and motion-capture cameras, researchers analyzed each participant’s natural gait to determine the optimal way to shift the load away from the knee’s medial (inner) compartment, where osteoarthritis is most common. This involved prescribing a personalized toe angle adjustment—either inward or outward—to reduce stress on the joint.

The Study: Method and Results

The year-long randomized control trial involved 68 participants with mild-to-moderate knee osteoarthritis. Half of the participants were in an intervention group and received personalized gait training. The other half were given a sham treatment, practicing a foot angle identical to their natural gait to control for the powerful placebo effect.

Participants in the intervention group underwent six weekly training sessions with biofeedback—a device that vibrated when they strayed from their prescribed foot angle. After the training period, they were encouraged to practice their new gait for at least 20 minutes a day until it became a natural habit.

After one year, the results were highly promising:

  • Pain Relief: Participants in the gait retraining group reported a decrease in knee pain that was comparable to the relief provided by over-the-counter medications like ibuprofen.
  • Slower Cartilage Degradation: Crucially, a second MRI showed that the intervention group experienced slower degradation of a key marker of cartilage health compared to the placebo group. This is a significant finding, as there is currently no way to reverse cartilage damage.

Filling a Critical Treatment Gap

This non-invasive intervention offers a major advantage, especially for younger patients with osteoarthritis who face decades of pain management before they become candidates for joint replacement surgery. The participants’ ability to adhere to the gait retraining over a long period, without the need for drugs or devices, further highlights its potential.

While the study’s initial use of expensive motion-capture technology needs to be streamlined, the researchers envision a future where this intervention can be prescribed in a physical therapy clinic and practiced at home using mobile sensors or “smart shoes.” The successful results of this trial lay a solid foundation for future studies and could ultimately fill a significant gap in treatment for a widespread and debilitating condition.

About the Author

Pharm'Up

Author

An E-platform for Pharma Learners

View All Posts

Post navigation

Previous: India’s Atomic Energy Department Drives Cancer Care with Indigenous Research and Affordable Technology
Next: Combination Therapy Offers New Hope for Advanced Triple-Negative Breast Cancer

Related Stories

Pharmup 4
2 min read
  • Pharma News

Future-Proofing Pharmacy: Saveetha College Webinar Explores the AI and IT Revolution

Pharm'Up
Pharmup 3
2 min read
  • Pharma News

Global Power Move: Sun Pharma’s $11.75 Billion Acquisition of Organon

Pharm'Up
Pharmup 2
2 min read
  • Pharma News

The Science of the “Super-Brush”: How Graphene Kills Bacteria Without Harming Humans

Pharm'Up

Recent Posts

  • Navigating Balance Disorders: Causes, Symptoms, and Management
  • Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief
  • Pharmacovigilance Specialist Opportunity at Bausch + Lomb
  • Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare
  • Sun Pharma Recruitment: Manager – EU Compliance (Tandalja R&D)

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025

Categories

  • Colleges
  • Conferences/ Workshops
  • Disease
  • Drugs
  • Events
  • Industries
  • Notes
  • Pharma Jobs
  • Pharma News
  • Previous Papers
  • Syllabus
  • Trainings/ Courses
  • Uncategorized

Read These Too

Pharmup 21
2 min read
  • Disease

Navigating Balance Disorders: Causes, Symptoms, and Management

Pharm'Up
Pharmup 20
1 min read
  • Disease

Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief

Pharm'Up
Pharmup 19
1 min read
  • Pharma Jobs

Pharmacovigilance Specialist Opportunity at Bausch + Lomb

Pharm'Up
Pharmup 18
1 min read
  • Pharma Jobs

Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare

Pharm'Up
  • YouTube
  • Facebook
  • LinkedIn
Copyright ©Pharm'UP All rights reserved by Eduversity India | MoreNews by AF themes.